British journal of anaesthesia · 2026
Consensus guideline from the European Malignant Hyperthermia Group on perioperative management of patients with an inherited primary disorder of skeletal muscle.
Consensus StatementСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Snoeck Marc M J, Gillies Robyn, Almeida da Silva Helga C, Rüffert Henrik, Girard Thierry, Hellblom Anna, Hopkins Philip M, Johannsen Stephan, Glahn Klaus P E, European Malignant Hyperthermia Group
Аннотация
Perioperative abnormalities presenting in patients with inherited primary disorders of skeletal muscle can share similar characteristics to those in a malignant hyperthermia crisis. These patients are often referred to malignant hyperthermia units for perioperative advice as clinicians are accessing conflicting and non-current literature. To address this, the European Malignant Hyperthermia Group (EMHG) has conducted a review of the current literature and used a formal consensus process, with review at annual EMHG meetings and workshops, to provide guidelines for the perioperative management of patients with these myopathies. The guidelines include general recommendations and suggestions applicable to all patients with myopathy requiring anaesthesia or procedural sedation and additional specific recommendations, suggestions and main concerns for patients with specific primary myopathies (ICD-11-CM) with inheritable pathology distal to the neuromuscular junction, including congenital, mitochondrial and metabolic myopathies; muscular dystrophies; myotonias; and familial periodic paralyses.